Citadel Advisors’s BlackRock Future Health ETF BMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,018
| Closed | -$377K | – | 13730 |
|
|
2026
Q1 | $377K | Buy |
13,018
+557
| +4% | +$16.9K | ﹤0.01% | 9943 |
|
|
2025
Q4 | $378K | Buy |
12,461
+3,368
| +37% | +$98.4K | ﹤0.01% | 9658 |
|
|
2025
Q3 | $244K | Sell |
9,093
-24,338
| -73% | -$624K | ﹤0.01% | 10815 |
|
|
2025
Q2 | $829K | Buy |
33,431
+23,663
| +242% | +$564K | ﹤0.01% | 7506 |
|
|
2025
Q1 | $237K | Buy |
9,768
+1,029
| +12% | +$26.4K | ﹤0.01% | 10111 |
|
|
2024
Q4 | $218K | Sell |
8,739
-28,809
| -77% | -$741K | ﹤0.01% | 10295 |
|
|
2024
Q3 | $981K | Buy |
37,548
+17,274
| +85% | +$447K | ﹤0.01% | 6903 |
|
|
2024
Q2 | $507K | Buy |
20,274
+6,666
| +49% | +$167K | ﹤0.01% | 8013 |
|
|
2024
Q1 | $359K | Sell |
13,608
-20,010
| -60% | -$509K | ﹤0.01% | 9089 |
|
|
2023
Q4 | $824K | Buy |
33,618
+5,836
| +21% | +$130K | ﹤0.01% | 7071 |
|
|
2023
Q3 | $624K | Buy |
27,782
+4,552
| +20% | +$109K | ﹤0.01% | 7583 |
|
|
2023
Q2 | $576K | Buy |
23,230
+2,728
| +13% | +$66.1K | ﹤0.01% | 7631 |
|
|
2023
Q1 | $481K | Buy |
20,502
+4,477
| +28% | +$105K | ﹤0.01% | 8403 |
|
|
2022
Q4 | $372K | Buy |
16,025
+1,845
| +13% | +$41.5K | ﹤0.01% | 8867 |
|
|
2022
Q3 | $297K | Sell |
14,180
-28,734
| -67% | -$651K | ﹤0.01% | 9604 |
|
|
2022
Q2 | $952K | Buy |
42,914
+27,891
| +186% | +$644K | ﹤0.01% | 7131 |
|
|
2022
Q1 | $381K | Buy |
15,023
+2,106
| +16% | +$53K | ﹤0.01% | 10034 |
|
|
2021
Q4 | $373K | Buy |
12,917
+1,607
| +14% | +$46.3K | ﹤0.01% | 10409 |
|
|
2021
Q3 | $332K | Buy |
11,310
+2,286
| +25% | +$68.8K | ﹤0.01% | 10842 |
|
|
2021
Q2 | $273K | Buy |
+9,024
| New | +$263K | ﹤0.01% | 11491 |
|
Other funds holding BMED
Citadel Advisors's BMED Position: Q2 2026 in Review
Citadel Advisors sold out of BlackRock Future Health ETF (BMED) in Q2 2026, closing a stake of 13,018 shares — an estimated $377K sold.
Citadel Advisors first reported a position in BMED in Q2 2021 and held it in 20 quarters. The position peaked at $981K in Q3 2024. 3 funds tracked by Wall St. Rank hold BMED as of Q2 2026.
- Citadel Advisors reported no remaining BlackRock Future Health ETF position as of Q2 2026 after selling out during the quarter.
- Citadel Advisors sold 13,018 BlackRock Future Health ETF shares in Q2 2026, an estimated $377K.
- Citadel Advisors first reported a position in BlackRock Future Health ETF in Q2 2021 and held it in 20 quarters.
- Citadel Advisors's BlackRock Future Health ETF position peaked at $981K in Q3 2024.
- 3 funds tracked by Wall St. Rank held BlackRock Future Health ETF as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.